BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boon LM, MacDonald DM, Mulliken JB. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg. 1999;104:1616-1623. [PMID: 10541160 DOI: 10.1097/00006534-199911000-00002] [Cited by in Crossref: 184] [Cited by in F6Publishing: 144] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Garmendía G, Miranda N, Borroso S, Longchong M, Martínez E, Ferrero J, Porrero P, López-saura P. Regression of Infancy Hemangiomas with Recombinant IFN-α2b. Journal of Interferon & Cytokine Research 2001;21:31-8. [DOI: 10.1089/107999001459132] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
2 Kim JH, Lam JM. Paediatrics: how to manage infantile haemangioma. Drugs Context 2021;10:2020-12-6. [PMID: 33889196 DOI: 10.7573/dic.2020-12-6] [Reference Citation Analysis]
3 Fay A, Nguyen J, Waner M. Conceptual approach to the management of infantile hemangiomas. J Pediatr 2010;157:881-8.e1-5. [PMID: 20884010 DOI: 10.1016/j.jpeds.2010.08.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
4 Grzesik P, Wu JK. Current perspectives on the optimal management of infantile hemangioma. Pediatric Health Med Ther 2017;8:107-16. [PMID: 29388636 DOI: 10.2147/PHMT.S115528] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Bruckner AL, Frieden IJ. Hemangiomas of infancy. Journal of the American Academy of Dermatology 2003;48:477-96. [DOI: 10.1067/mjd.2003.200] [Cited by in Crossref: 238] [Cited by in F6Publishing: 162] [Article Influence: 12.5] [Reference Citation Analysis]
6 Barzilay D, Metzker A, Brenner S. Some Considerations On Hemangioma. SKINmed: Dermatology for the Clinician 2007;1:47-9. [DOI: 10.1111/j.1540-9740.2002.01744.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
7 Lanigan S. Treatment of vascular naevi in children. Hospital Medicine 2001;62:144-7. [DOI: 10.12968/hosp.2001.62.3.1532] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
8 Bauland CG, Smit JM, Ketelaars R, Rieu PN, Spauwen PH. Management of haemangiomas of infancy: A retrospective analysis and a treatment protocol. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery 2009;42:86-91. [DOI: 10.1080/02844310801924167] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
9 Men CJ, Ediriwickrema LS, Paik JS, Murdock J, Yen MT, Ng JD, Liu CY, Korn BS, Kikkawa DO. Surgical Intervention of Periocular Infantile Hemangiomas in the Era of β-Blockers. Ophthalmic Plast Reconstr Surg 2020;36:70-3. [PMID: 31809485 DOI: 10.1097/IOP.0000000000001466] [Reference Citation Analysis]
10 Ni N, Wagner RS, Langer P, Guo S. New Developments in the Management of Periocular Capillary Hemangioma in Children. J Pediatr Ophthalmol Strabismus 2011;48:269-76. [DOI: 10.3928/01913913-20101018-02] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
11 Ritter MR, Butschek RA, Friedlander M, Friedlander SF. Pathogenesis of infantile haemangioma: new molecular and cellular insights. Expert Rev Mol Med 2007;9:1-19. [PMID: 18045510 DOI: 10.1017/S146239940700052X] [Cited by in Crossref: 49] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
12 Yang Y, Sun M, Cheng X, Hu X, Zhang P, Ma Q, Li J, Tian L, Lei D. Bleomycin A5 plus dexamethasone for control of growth in infantile parotid hemangiomas. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2009;108:62-9. [DOI: 10.1016/j.tripleo.2009.02.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
13 Nicolae C, Olsen BR. Unexpected matrix diseases and novel therapeutic strategies. Cell Tissue Res 2010;339:155-65. [PMID: 19813027 DOI: 10.1007/s00441-009-0874-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
14 Uysal KM, Olgun N, Erbay A, Sarialioğlu F. High-dose oral methylprednisolone therapy in childhood hemangiomas. Pediatr Hematol Oncol 2001;18:335-41. [PMID: 11452405 DOI: 10.1080/088800101300312609] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
15 Arneja JS, Mulliken JB. Resection of Amblyogenic Periocular Hemangiomas: Indications and Outcomes: . Plastic and Reconstructive Surgery 2010;125:274-81. [DOI: 10.1097/prs.0b013e3181c49708] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
16 Weiss I, O TM, Lipari BA, Meyer L, Berenstein A, Waner M. Current treatment of parotid hemangiomas. Laryngoscope 2011;121:1642-50. [PMID: 21766313 DOI: 10.1002/lary.21358] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
17 Zvizdic D, Bulja D, Sidran A, Skenderi F, Zvizdic Z, Vranic S. Isolated deep orbital hemangioma treated successfully with oral propranolol in a 2-month-old infant: Case report with literature review. Am J Ophthalmol Case Rep 2021;22:101095. [PMID: 33981915 DOI: 10.1016/j.ajoc.2021.101095] [Reference Citation Analysis]
18 Goddard DS, Liang MG, Chamlin SL, Svoren BM, Spack NP, Mulliken JB. Hypopituitarism in PHACES Association. Pediatr Dermatol 2006;23:476-80. [DOI: 10.1111/j.1525-1470.2006.00287.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
19 Watters K, O'Marcaigh A, Canny G, Russell J. Management of a large bronchial haemangioma in an infant. Int J Pediatr Otorhinolaryngol 2003;67:429-33. [PMID: 12663120 DOI: 10.1016/s0165-5876(02)00403-2] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
20 Nieuwenhuis K, de Laat PCJ, Janmohamed SR, Madern GC, Oranje AP. Infantile Hemangioma: Treatment with Short Course Systemic Corticosteroid Therapy as an Alternative for Propranolol: Infantile Hemangioma: Treatment with Short Course Systemic Corticosteroid Therapy. Pediatric Dermatology 2013;30:64-70. [DOI: 10.1111/j.1525-1470.2012.01846.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
21 Ames JA, Sykes JM. Current trends in medical management of infantile hemangioma. Curr Opin Otolaryngol Head Neck Surg. 2015;23:286-291. [PMID: 26101875 DOI: 10.1097/moo.0000000000000170] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
22 Boon L, Bataille A, Bernier V, Vermylen C, Verellen G. Traitement médical des hémangiomes immatures. Annales de Chirurgie Plastique Esthétique 2006;51:310-20. [DOI: 10.1016/j.anplas.2006.07.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
23 Lomenick JP, Backeljauw PF, Lucky AW. Growth, Bone Mineral Accretion, and Adrenal Function in Glucocorticoid-Treated Infants with Hemangiomas - A Retrospective Study. Pediatr Dermatol 2006;23:169-74. [DOI: 10.1111/j.1525-1470.2006.00207.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
24 Barry RBM, Hughes BR, Cook LJ. Involution of infantile haemangiomas after imiquimod 5% cream. Clin Exp Dermatol 2008;33:446-9. [DOI: 10.1111/j.1365-2230.2007.02676.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
25 Spring MA, Bentz ML. Cutaneous Vascular Lesions. Clinics in Plastic Surgery 2005;32:171-86. [DOI: 10.1016/j.cps.2004.11.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
26 Frieden IJ, Haggstrom AN, Drolet BA, Mancini AJ, Friedlander SF, Boon L, Chamlin SL, Baselga E, Garzon MC, Nopper AJ, Siegel DH, Mathes EW, Goddard DS, Bischoff J, North PE, Esterly NB. Infantile Hemangiomas: Current Knowledge, Future Directions. Proceedings of a Research Workshop on Infantile Hemangiomas . April 7-9, 2005 Bethesda, Maryland. Pediatr Dermatol 2005;22:383-406. [DOI: 10.1111/j.1525-1470.2005.00102.x] [Cited by in Crossref: 231] [Cited by in F6Publishing: 177] [Article Influence: 13.6] [Reference Citation Analysis]
27 Su WT, Xue JX, Ke YH. Noteworthy effects of a long-pulse Alexandrite laser for treatment of high-risk infantile hemangioma: A case report and literature review. World J Clin Cases 2019; 7(14): 1876-1883 [PMID: 31417934 DOI: 10.12998/wjcc.v7.i14.1876] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Aly MM, Hamza AF, Abdel Kader HM, Saafan HA, Ghazy MS, Ragab IA. Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma. Eur J Pediatr 2015;174:1503-9. [PMID: 25982338 DOI: 10.1007/s00431-015-2561-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
29 Akcay A, Karakas Z, Saribeyoglu ET, Unuvar A, Baykal C, Garipardic M, Anak S, Agaoglu L, Ozturk G, Devecioglu O. Infantile hemangiomas, complications and follow-up. Indian Pediatr 2012;49:805-9. [PMID: 22791668 DOI: 10.1007/s13312-012-0193-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
30 Ceisler EJ, Santos L, Blei F. Periocular Hemangiomas: What Every Physician Should Know. Pediatr Dermatol 2004;21:1-9. [DOI: 10.1111/j.0736-8046.2004.21101.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
31 Pascual-castroviejo I, López-gutiérrez J, Pascual-pascual S, Rafia S, Alarcón-palacio J. Hemangiomas y malformaciones vasculares cutáneas y patología asociada. Un nuevo síndrome neurocutáneo. Anales de Pediatría 2003;58:339-49. [DOI: 10.1016/s1695-4033(03)78068-0] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
32 Hunzeker CM, Geronemus RG. Treatment of superficial infantile hemangiomas of the eyelid using the 595-nm pulsed dye laser. Dermatol Surg. 2010;36:590-597. [PMID: 20384759 DOI: 10.1111/j.1524-4725.2010.01511.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
33 Clune JE, Greene AK, Guo CY, Gao LL, Kim S, Meara JG, Proctor MR, Mulliken JB, Rogers GF. Perioperative corticosteroid reduces hospital stay after fronto-orbital advancement. J Craniofac Surg 2010;21:344-8. [PMID: 20186083 DOI: 10.1097/SCS.0b013e3181cf6103] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
34 Hansen SL, Dosanjh A, Young DM, Boudreau N, Hoffman WY. Hemangiomas and homeobox gene expression. J Craniofac Surg 2006;17:767-71. [PMID: 16877932 DOI: 10.1097/00001665-200607000-00031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
35 Enjolras O, Brevière G, Roger G, Tovi M, Pellegrino B, Varotti E, Soupre V, Picard A, Leverger G. Traitement par vincristine des hémangiomes graves du nourrisson. Archives de Pédiatrie 2004;11:99-107. [DOI: 10.1016/j.arcped.2003.10.014] [Cited by in Crossref: 109] [Cited by in F6Publishing: 80] [Article Influence: 6.1] [Reference Citation Analysis]
36 Yu Y, Wylie-Sears J, Boscolo E, Mulliken JB, Bischoff J. Genomic imprinting of IGF2 is maintained in infantile hemangioma despite its high level of expression. Mol Med 2004;10:117-23. [PMID: 15706404 DOI: 10.2119/2004-00045.Bischoff] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
37 Zaman F, Zhao Y, Celvin B, Mehta HH, Wan J, Chrysis D, Ohlsson C, Fadeel B, Cohen P, Sävendahl L. Humanin is a novel regulator of Hedgehog signaling and prevents glucocorticoid-induced bone growth impairment. FASEB J 2019;33:4962-74. [PMID: 30657335 DOI: 10.1096/fj.201801741R] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
38 Yen KG, Hussein MA. Oral Propranolol in the Management of Periocular Capillary Hemangiomas. International Ophthalmology Clinics 2013;53:143-51. [DOI: 10.1097/iio.0b013e31828b7b97] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Wananukul S, Nuchprayoon I, Seksarn P. Treatment of Kasabach-Merritt syndrome: a stepwise regimen of prednisolone, dipyridamole, and interferon. Int J Dermatol 2003;42:741-8. [DOI: 10.1046/j.1365-4362.2003.01796.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
40 Moyakine AV, Vleuten CJVD. Propranolol for infantile hemangioma: Current state of affairs. World J Dermatol 2016; 5(1): 4-16 [DOI: 10.5314/wjd.v5.i1.4] [Reference Citation Analysis]
41 Mhanna A, Franklin WH, Mancini AJ. Hepatic Infantile Hemangiomas Treated with Oral Propranolol-A Case Series: Hepatic Infantile Hemangiomas. Pediatric Dermatology 2011;28:39-45. [DOI: 10.1111/j.1525-1470.2010.01355.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
42 Gnarra M, Behr G, Kitajewski A, Wu JK, Anupindi SA, Shawber CJ, Zavras N, Schizas D, Salakos C, Economopoulos KP. History of the infantile hepatic hemangioma: From imaging to generating a differential diagnosis. World J Clin Pediatr 2016; 5(3): 273-280 [PMID: 27610342 DOI: 10.5409/wjcp.v5.i3.273] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
43 Boscolo E, Bischoff J. Vasculogenesis in infantile hemangioma. Angiogenesis. 2009;12:197-207. [PMID: 19430954 DOI: 10.1007/s10456-009-9148-2] [Cited by in Crossref: 112] [Cited by in F6Publishing: 91] [Article Influence: 8.6] [Reference Citation Analysis]
44 Fridman G, Grieser E, Hill R, Khuddus N, Bersani T, Slonim C. Propranolol for the Treatment of Orbital Infantile Hemangiomas. Ophthalmic Plastic & Reconstructive Surgery 2011;27:190-4. [DOI: 10.1097/iop.0b013e318201d344] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
45 Zhang WJ, Wu LQ, Liu HL, Ye LY, Xin YL, Grau GE, Lou JN. Abnormal blood vessels formed by human liver cavernous hemangioma endothelial cells in nude mice are suitable for drug evaluation. Microvasc Res 2009;78:379-85. [PMID: 19729028 DOI: 10.1016/j.mvr.2009.08.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
46 Yuzuriha S, Nagai F, Noguchi M. How to Manage Disfiguring Scars in Involuted Infantile Hemangioma. Adv Wound Care (New Rochelle) 2019;8:221-9. [PMID: 31737416 DOI: 10.1089/wound.2018.0847] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Rössler J, Braunschweiger F, Schill T. [Medication-based therapy of infantile hemangioma and lymphatic malformations]. HNO 2014;62:12-8. [PMID: 24434958 DOI: 10.1007/s00106-013-2794-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
48 Gontijo B, Silva CMR, Pereira LB. Hemangioma da infância. An Bras Dermatol 2003;78:651-73. [DOI: 10.1590/s0365-05962003000600002] [Cited by in Crossref: 9] [Article Influence: 0.5] [Reference Citation Analysis]
49 Stith JA. Current diagnostics in office practice evaluation and nonoperative management of vascular malformations: . Current Opinion in Otolaryngology & Head and Neck Surgery 2000;8:448-53. [DOI: 10.1097/00020840-200012000-00002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
50 Ritter MR, Moreno SK, Dorrell MI, Rubens J, Ney J, Fallon Friedlander D, Bergman J, Cunningham BB, Eichenfield L, Reinisch J, Cohen S, Veccione T, Holmes R, Fallon Friedlander S, Friedlander M. Identifying Potential Regulators of Infantile Hemangioma Progression through Large-scale Expression Analysis: A Possible Role for the Immune System and Indoleamine 2,3 Dioxygenase (IDO) during Involution. Lymphatic Research and Biology 2003;1:291-9. [DOI: 10.1089/153968503322758094] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 1.9] [Reference Citation Analysis]
51 Andersson NW, Skov L, Andersen JT. Evaluation of Topical Corticosteroid Use in Pregnancy and Risk of Newborns Being Small for Gestational Age and Having Low Birth Weight. JAMA Dermatol 2021;157:788-95. [PMID: 33950165 DOI: 10.1001/jamadermatol.2021.1090] [Reference Citation Analysis]
52 Blanke K, Dähnert I, Salameh A. Role of connexins in infantile hemangiomas. Front Pharmacol 2013;4:41. [PMID: 23596415 DOI: 10.3389/fphar.2013.00041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
53 Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, Chun RH, Garzon MC, Holland KE, Liberman L. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131:128-140. [PMID: 23266923 DOI: 10.1542/peds.2012-1691] [Cited by in Crossref: 304] [Cited by in F6Publishing: 219] [Article Influence: 30.4] [Reference Citation Analysis]
54 Greene AK. Current Concepts of Vascular Anomalies. Journal of Craniofacial Surgery 2012;23:220-4. [DOI: 10.1097/scs.0b013e318241b8cc] [Cited by in Crossref: 27] [Cited by in F6Publishing: 1] [Article Influence: 2.7] [Reference Citation Analysis]
55 Ceisler E, Blei F. Ophthalmic Issues in Hemangiomas of Infancy. Lymphatic Research and Biology 2003;1:321-30. [DOI: 10.1089/153968503322758148] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
56 Burns AJ, Navarro JA, Cooner RD. Classification of Vascular Anomalies and the Comprehensive Treatment of Hemangiomas: . Plastic and Reconstructive Surgery 2009;124:69e-81e. [DOI: 10.1097/prs.0b013e3181aa1015] [Cited by in Crossref: 28] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
57 Smolinski KN, Yan AC. Hemangiomas of Infancy: Clinical and Biological Characteristics. Clin Pediatr (Phila) 2005;44:747-66. [DOI: 10.1177/000992280504400902] [Cited by in Crossref: 57] [Cited by in F6Publishing: 40] [Article Influence: 9.5] [Reference Citation Analysis]
58 Claude O, Picard A, O'sullivan N, Baccache S, Momtchilova M, Enjolras O, Vazquez M, Diner P. Use of ultrasonic dissection in the early surgical management of periorbital haemangiomas. Journal of Plastic, Reconstructive & Aesthetic Surgery 2008;61:1479-85. [DOI: 10.1016/j.bjps.2007.09.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
59 Blei F. Vascular anomalies: From bedside to bench and back again. Current Problems in Pediatric and Adolescent Health Care 2002;32:72-93. [DOI: 10.1067/mps.2002.125533] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
60 Ethunandan M, Mellor TK. Haemangiomas and vascular malformations of the maxillofacial region--a review. Br J Oral Maxillofac Surg 2006;44:263-72. [PMID: 16107299 DOI: 10.1016/j.bjoms.2005.06.032] [Cited by in Crossref: 96] [Cited by in F6Publishing: 58] [Article Influence: 5.6] [Reference Citation Analysis]
61 Mallo S, Torrelo A, Zambrano A. Tratamiento de hemangiomas infantiles con corticoides orales. Actas Dermo-Sifiliográficas 2004;95:370-3. [DOI: 10.1016/s0001-7310(04)76836-2] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
62 Sethuraman G, Yenamandra VK, Gupta V. Management of infantile hemangiomas: current trends. J Cutan Aesthet Surg 2014;7:75-85. [PMID: 25136206 DOI: 10.4103/0974-2077.138324] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
63 Sulzberger L, Baillie R, Itinteang T, de Jong S, Marsh R, Leadbitter P, Tan S. Serum levels of renin, angiotensin-converting enzyme and angiotensin II in patients treated by surgical excision, propranolol and captopril for problematic proliferating infantile haemangioma. Journal of Plastic, Reconstructive & Aesthetic Surgery 2016;69:381-6. [DOI: 10.1016/j.bjps.2015.10.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
64 Craig LM, Alster TS. Vascular Skin Lesions in Children: A Review of Laser Surgical and Medical Treatments. Dermatologic Surgery 2013;39:1137-46. [DOI: 10.1111/dsu.12129] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
65 Greenberger S, Yuan S, Walsh LA, Boscolo E, Kang KT, Matthews B, Mulliken JB, Bischoff J. Rapamycin suppresses self-renewal and vasculogenic potential of stem cells isolated from infantile hemangioma. J Invest Dermatol. 2011;131:2467-2476. [PMID: 21938011 DOI: 10.1038/jid.2011.300] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 5.5] [Reference Citation Analysis]
66 Phan TA, Adams S, Wargon O. Segmental haemangiomas of infancy: A review of 14 cases. Australas J Dermatol 2006;47:242-7. [DOI: 10.1111/j.1440-0960.2006.00289.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
67 Gampper TJ, Morgan RF. Vascular Anomalies: Hemangiomas: . Plastic and Reconstructive Surgery 2002;110:572-85. [DOI: 10.1097/00006534-200208000-00032] [Cited by in Crossref: 68] [Cited by in F6Publishing: 53] [Article Influence: 3.4] [Reference Citation Analysis]
68 Gong H, Xu DP, Li YX, Cheng C, Li G, Wang XK. Evaluation of the efficacy and safety of propranolol, timolol maleate, and the combination of the two, in the treatment of superficial infantile haemangiomas. Br J Oral Maxillofac Surg 2015;53:836-40. [PMID: 26427968 DOI: 10.1016/j.bjoms.2015.09.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
69 de Graaf M, Breur JMPJ, Raphaël MF, Vos M, Breugem CC, Pasmans SGMA. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants. J Am Acad Dermatol 2011;65:320-7. [PMID: 21601311 DOI: 10.1016/j.jaad.2010.06.048] [Cited by in Crossref: 130] [Cited by in F6Publishing: 100] [Article Influence: 11.8] [Reference Citation Analysis]
70 Avery G, Davis C, Tan ST. Hemangioma causing deformational plagiocephaly. J Craniofac Surg 2011;22:223-5. [PMID: 21233747 DOI: 10.1097/SCS.0b013e3181f76098] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
71 Moss C, Shahidullah H. Naevi and other Developmental Defects. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's Textbook of Dermatology. Oxford: Wiley-Blackwell; 2010. pp. 1-107. [DOI: 10.1002/9781444317633.ch18] [Cited by in Crossref: 14] [Article Influence: 1.2] [Reference Citation Analysis]
72 Mahadevan M, Cheng A, Barber C. Treatment of subglottic hemangiomas with propranolol: initial experience in 10 infants: Subglottic hemangioma and beta blockers. ANZ Journal of Surgery 2011;81:456-61. [DOI: 10.1111/j.1445-2197.2010.05643.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
73 Rössler J, Wehl G, Niemeyer CM. Evaluating systemic prednisone therapy for proliferating haemangioma in infancy. Eur J Pediatr 2008;167:813-5. [DOI: 10.1007/s00431-007-0561-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
74 Adams DM, Lucky AW. Cervicofacial vascular anomalies. I. Hemangiomas and other benign vascular tumors. Semin Pediatr Surg. 2006;15:124-132. [PMID: 16616316 DOI: 10.1053/j.sempedsurg.2006.02.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
75 Alomari AI. Comments on imaging and management of hepatic hemangiomas. Pediatr Radiol 2009;39:637-8. [DOI: 10.1007/s00247-009-1244-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
76 Emsen IM. Preoperative treatment of a parotid hemangioma with 100% ethyl alcohol. Can J Plast Surg 2008;16:239-40. [PMID: 19949507 DOI: 10.1177/229255030801600408] [Reference Citation Analysis]
77 Zide BM, Levine SM. Hemangioma Update: Pearls From 30 Years of Treatment. Annals of Plastic Surgery 2012;69:99-103. [DOI: 10.1097/sap.0b013e3182212881] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
78 Satterfield KR, Chambers CB. Current Treatment and Management of Infantile Hemangiomas. Surv Ophthalmol. 2019; Epub ahead of print. [PMID: 30772366 DOI: 10.1016/j.survophthal.2019.02.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
79 Mahalingam S, Luke L, Pundir J, Pundir V. The role of adjuvant systemic steroids in the management of periorbital cellulitis secondary to sinusitis: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol 2021;278:2193-201. [PMID: 32833055 DOI: 10.1007/s00405-020-06294-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
80 Kim J, Hong JW, Roh TS, Lee WJ. Oral propranolol therapy in 23 infants with infantile hemangioma. Arch Plast Surg 2018;45:517-24. [PMID: 30466231 DOI: 10.5999/aps.2018.00318] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
81 Aviles R, Boyce TG, Thompson DM. Pneumocystis carinii Pneumonia in a 3-Month-Old Infant Receiving High-Dose Corticosteroid Therapy for Airway Hemangiomas. Mayo Clinic Proceedings 2004;79:243-5. [DOI: 10.4065/79.2.243] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
82 Lou Y, Peng WJ, Cao Y, Cao DS, Xie J, Li HH. The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies. Br J Clin Pharmacol. 2014;78:44-57. [PMID: 24033819 DOI: 10.1111/bcp.12235] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
83 Chaturvedi K, Steinberg JS, Snyder CS. Cost-effectiveness of treating infantile haemangioma with propranolol in an outpatient setting. Cardiol Young 2018;28:1105-8. [DOI: 10.1017/s1047951118000987] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
84 Reinisch JF, Kim RY, Harshbarger RJ, Meara JG. Surgical Management of Parotid Hemangioma: . Plastic and Reconstructive Surgery 2004;113:1940-8. [DOI: 10.1097/01.prs.0000122205.50329.e1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
85 Azzopardi S, Wright TC. Novel Strategies for Managing Infantile Hemangiomas: A Review. Annals of Plastic Surgery 2012;68:226-8. [DOI: 10.1097/sap.0b013e318216b4f8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
86 George M, Singhal V, Sharma V, Nopper AJ. Successful Surgical Excision of a Complex Vascular Lesion in an Infant with Kasabach–Merritt Syndrome. Pediatric Dermatology 2002;19:340-4. [DOI: 10.1046/j.1525-1470.2002.t01-1-00097.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
87 Pascual-castroviejo I. Cutaneous hemangiomas: vascular anomaly complex. In: Roach ES, Miller VS, editors. Neurocutaneous Disorders. Cambridge University Press; 2009. pp. 172-8. [DOI: 10.1017/cbo9780511545054.024] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
88 Uebelhoer M, Boon LM, Vikkula M. Vascular anomalies: from genetics toward models for therapeutic trials. Cold Spring Harb Perspect Med 2012;2:a009688. [PMID: 22908197 DOI: 10.1101/cshperspect.a009688] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
89 Bigorre M, Van Kien AK, Valette H. Beta-Blocking Agent for Treatment ofInfantile Hemangioma: . Plastic and Reconstructive Surgery 2009;123:195e-6e. [DOI: 10.1097/prs.0b013e3181a3f435] [Cited by in Crossref: 45] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
90 Schwartz RA, Sidor MI, Musumeci ML, Lin RL, Micali G. Infantile haemangiomas: a challenge in paediatric dermatology. J Eur Acad Dermatol Venereol. 2010;24:631-638. [PMID: 20565561 DOI: 10.1111/j.1468-3083.2010.03650.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
91 Kwon EK, Seefeldt M, Drolet BA. Infantile hemangiomas: an update. Am J Clin Dermatol 2013;14:111-23. [PMID: 23338947 DOI: 10.1007/s40257-013-0008-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
92 Hochhauser CJ, Lewis M, Kamen BA, Cole PD. Steroid-induced alterations of mood and behavior in children during treatment for acute lymphoblastic leukemia. Support Care Cancer 2005;13:967-74. [PMID: 16189647 DOI: 10.1007/s00520-005-0882-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
93 Vogel AM, Alesbury JM, Fox VL, Fishman SJ. Complex pancreatic vascular anomalies in children. J Pediatr Surg 2006;41:473-8. [PMID: 16516618 DOI: 10.1016/j.jpedsurg.2005.10.079] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
94 Higuera S, Gordley K, Metry DW, Stal S. Management of Hemangiomas and Pediatric Vascular Malformations: . Journal of Craniofacial Surgery 2006;17:783-9. [DOI: 10.1097/00001665-200607000-00034] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
95 Tang R, Xian D, Xu J, Peng H, Pan S, Zhong J. Proanthocyanidins as a Potential Novel Way for the Treatment of Hemangioma. Biomed Res Int 2021;2021:5695378. [PMID: 33490272 DOI: 10.1155/2021/5695378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Hsi Dickie B, Fishman SJ, Azizkhan RG. Hepatic vascular tumors. Semin Pediatr Surg. 2014;23:168-172. [PMID: 25241093 DOI: 10.1053/j.sempedsurg.2014.06.018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 3.9] [Reference Citation Analysis]
97 Fevurly RD, Fishman SJ. Vascular Anomalies in Pediatrics. Surgical Clinics of North America 2012;92:769-800. [DOI: 10.1016/j.suc.2012.03.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
98 Barrio VR, Drolet BA. Treatment of hemangiomas of infancy. Dermatol Ther 2005;18:151-9. [PMID: 15953144 DOI: 10.1111/j.1529-8019.2005.05018.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
99 Greene AK. Systemic corticosteroid is effective and safe treatment for problematic infantile hemangioma. Pediatr Dermatol 2010;27:322-3. [PMID: 20609168 DOI: 10.1111/j.1525-1470.2010.01157.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
100 Chang CS, Wong A, Rohde CH, Ascherman JA, Wu JK. Management of lip hemangiomas: Minimizing peri-oral scars. J Plast Reconstr Aesthet Surg 2012;65:163-8. [PMID: 21937296 DOI: 10.1016/j.bjps.2011.08.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
101 Dhellemmes P, Brevière GM, Degrugillier-Chopinet C, Vinchon M. [Vascular lesions of the orbit in children]. Neurochirurgie 2010;56:271-80. [PMID: 20347458 DOI: 10.1016/j.neuchi.2010.02.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
102 Williams LC, Nesbitt LT. UPDATE ON SYSTEMIC GLUCOCORTICOSTEROIDS IN DERMATOLOGY. Dermatologic Clinics 2001;19:63-77. [DOI: 10.1016/s0733-8635(05)70230-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
103 Sawa K, Yazdani A, Rieder MJ, Filler G. Propranolol therapy for infantile hemangioma is less toxic but longer in duration than corticosteroid therapy. Plast Surg (Oakv) 2014;22:233-6. [PMID: 25535459 DOI: 10.4172/plastic-surgery.1000892] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
104 Xu D, Cao R, Xue L, Sun N, Tong S, Wang X. Treatment of Severe Infantile Hemangiomas With Propranolol: An Evaluation of the Efficacy and Effects of Cardiovascular Parameters in 25 Consecutive Patients. Journal of Oral and Maxillofacial Surgery 2015;73:430-6. [DOI: 10.1016/j.joms.2014.09.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
105 Tangtiphaiboontana J, Hess CP, Bayer M, Drolet BA, Nassif LM, Metry DW, Barkovich AJ, Frieden IJ, Fullerton HJ. Neurodevelopmental abnormalities in children with PHACE syndrome. J Child Neurol 2013;28:608-14. [PMID: 22805249 DOI: 10.1177/0883073812450073] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
106 Marler JJ, Mulliken JB. Current management of hemangiomas and vascular malformations. Clin Plast Surg 2005;32:99-116, ix. [PMID: 15636768 DOI: 10.1016/j.cps.2004.10.001] [Cited by in Crossref: 178] [Cited by in F6Publishing: 110] [Article Influence: 10.5] [Reference Citation Analysis]
107 Itinteang T, Withers AHJ, Leadbitter P, Day DJ, Tan ST. Pharmacologic therapies for infantile hemangioma: is there a rational basis? Plast Reconstr Surg 2011;128:499-507. [PMID: 21788841 DOI: 10.1097/PRS.0b013e31821b63a0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
108 Berenguer B, de Salamanca JE, González B, Rodríguez P, Zambrano A, Higueras AP. Large Involuted Facial Hemangioma Treated with Syringe Liposuction: . Plastic and Reconstructive Surgery 2003;111:314-8. [DOI: 10.1097/00006534-200301000-00053] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
109 Izadpanah A, Izadpanah A, Kanevsky J, Belzile E, Schwarz K. Propranolol versus corticosteroids in the treatment of infantile hemangioma: a systematic review and meta-analysis. Plast Reconstr Surg. 2013;131:601-613. [PMID: 23142941 DOI: 10.1097/prs.0b013e31827c6fab] [Cited by in Crossref: 68] [Cited by in F6Publishing: 22] [Article Influence: 7.6] [Reference Citation Analysis]
110 Itinteang T, Brasch HD, Tan ST, Day DJ. Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution. J Plast Reconstr Aesthet Surg. 2011;64:759-765. [PMID: 20870476 DOI: 10.1016/j.bjps.2010.08.039] [Cited by in Crossref: 113] [Cited by in F6Publishing: 92] [Article Influence: 9.4] [Reference Citation Analysis]
111 Belen B, Oguz A, Okur A, Dalgic B. A complication to be aware of: hyperkalaemia following propranolol therapy for an infant with intestinal haemangiomatozis. BMJ Case Rep 2014;2014:bcr2014203746. [PMID: 24842358 DOI: 10.1136/bcr-2014-203746] [Cited by in Crossref: 8] [Article Influence: 1.0] [Reference Citation Analysis]
112 Enjolras O, Garzon MC. Vascular Stains, Malformations, and Tumors. Neonatal Dermatology. Elsevier; 2008. pp. 343-74. [DOI: 10.1016/b978-1-4160-3432-2.50023-6] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
113 Ni N, Guo S, Langer P. Current concepts in the management of periocular infantile (capillary) hemangioma. Curr Opin Ophthalmol 2011;22:419-25. [PMID: 21730838 DOI: 10.1097/ICU.0b013e32834994b4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
114 Moodley ST, Hudson DA, Adams S, Adams KG. Shouldn't Propranolol Be Used to Treat All Haemangiomas? Aesthetic Plast Surg 2015;39:963-7. [PMID: 26377820 DOI: 10.1007/s00266-015-0557-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
115 Perkins JA, Chen EY. Vascular Anomalies of the Head and Neck. Cummings Otolaryngology - Head and Neck Surgery. Elsevier; 2010. pp. 2822-34. [DOI: 10.1016/b978-0-323-05283-2.00200-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
116 Grover C, Kedar A, Arora P, Lal B. Efficacy of oral prednisolone use in the treatment of infantile hemangiomas in Indian children. Pediatr Dermatol. 2011;28:502-506. [PMID: 21692837 DOI: 10.1111/j.1525-1470.2011.01491.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
117 Miller T, Frieden IJ. Hemangiomas: New Insights and Classification. Pediatr Ann 2005;34:179-87. [DOI: 10.3928/0090-4481-20050301-07] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
118 Rotter A, de Oliveira ZNP. Infantile hemangioma: pathogenesis and mechanisms of action of propranolol. J Dtsch Dermatol Ges 2017;15:1185-90. [PMID: 29193649 DOI: 10.1111/ddg.13365] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
119 Foley LS, Kulungowski AM. Vascular Anomalies in Pediatrics. Advances in Pediatrics 2015;62:227-55. [DOI: 10.1016/j.yapd.2015.04.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
120 Rotter A, de Oliveira ZNP. Das infantile Hämangiom: Pathogenese und Wirkmechanismus von Propranolol. J Dtsch Dermatol Ges 2017;15:1185-91. [PMID: 29228484 DOI: 10.1111/ddg.13365_g] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
121 Pascual-castroviejo I. Vascular Birthmarks of Infancy: Phace Association (Pascual-Castroviejo Type II Syndrome) and Cobb Syndrome. In: Ruggieri M, Pascual-castroviejo I, Di Rocco C, editors. Neurocutaneous Disorders Phakomatoses and Hamartoneoplastic Syndromes. Vienna: Springer; 2008. pp. 19-49. [DOI: 10.1007/978-3-211-69500-5_2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
122 Lv M, Fan X, Su L. Propranolol for problematic head and neck hemangiomas: An analysis of 37 consecutive patients. International Journal of Pediatric Otorhinolaryngology 2012;76:574-8. [DOI: 10.1016/j.ijporl.2012.01.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
123 Tan ST, Itinteang T, Leadbitter P. Low-dose propranolol for infantile haemangioma. Journal of Plastic, Reconstructive & Aesthetic Surgery 2011;64:292-9. [DOI: 10.1016/j.bjps.2010.06.010] [Cited by in Crossref: 83] [Cited by in F6Publishing: 66] [Article Influence: 7.5] [Reference Citation Analysis]
124 Chisholm KM, Chang KW, Truong MT, Kwok S, West RB, Heerema-McKenney AE. β-Adrenergic receptor expression in vascular tumors. Mod Pathol 2012;25:1446-51. [PMID: 22743651 DOI: 10.1038/modpathol.2012.108] [Cited by in Crossref: 60] [Cited by in F6Publishing: 69] [Article Influence: 6.0] [Reference Citation Analysis]
125 Aljebab F, Choonara I, Conroy S. Systematic Review of the Toxicity of Long-Course Oral Corticosteroids in Children. PLoS One 2017;12:e0170259. [PMID: 28125632 DOI: 10.1371/journal.pone.0170259] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 9.8] [Reference Citation Analysis]
126 Adams DM, Wentzel MS. The Role of the Hematologist/Oncologist in the Care of Patients with Vascular Anomalies. Pediatric Clinics of North America 2008;55:339-55. [DOI: 10.1016/j.pcl.2008.01.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
127 Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Current Problems in Surgery 2000;37:517-84. [DOI: 10.1016/s0011-3840(00)80013-1] [Cited by in Crossref: 381] [Cited by in F6Publishing: 72] [Article Influence: 17.3] [Reference Citation Analysis]
128 Dinehart SM, Kincannon J, Geronemus R. Hemangiomas: Evaluation and Treatment. Dermatol Surg 2001;27:475-85. [DOI: 10.1046/j.1524-4725.2001.00227.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
129 Chen L, Silverman N, Wu A, Shinder R. Intravenous Steroids With Antibiotics on Admission for Children With Orbital Cellulitis. Ophthalmic Plast Reconstr Surg 2018;34:205-8. [PMID: 28369021 DOI: 10.1097/IOP.0000000000000910] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 5.5] [Reference Citation Analysis]
130 Beck DO, Gosain AK. The Presentation and Management of Hemangiomas: . Plastic and Reconstructive Surgery 2009;123:181e-91e. [DOI: 10.1097/prs.0b013e3181a65c59] [Cited by in Crossref: 35] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
131 Frank R, Cowan B, Harrop A, Astle W, Mcphalen D. Visual development in infants: visual complications of periocular haemangiomas. Journal of Plastic, Reconstructive & Aesthetic Surgery 2010;63:1-8. [DOI: 10.1016/j.bjps.2008.08.045] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
132 Pokorny JJ, Roth F, Balfour I, Rinehart G. An unusual complication of the treatment of a hemangioma. Ann Plast Surg 2002;48:83-7. [PMID: 11773735 DOI: 10.1097/00000637-200201000-00012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
133 Eppley BL. Pediatric Plastic Surgery Revisited. Clinics in Plastic Surgery 2001;28:731-44. [DOI: 10.1016/s0094-1298(20)32419-6] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
134 Todorovich SM, Khan ZA. Elevated T-box 2 in infantile hemangioma stem cells maintains an adipogenic differentiation-competent state. Dermatoendocrinol 2013;5:352-7. [PMID: 24516689 DOI: 10.4161/derm.26739] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
135 Sundine MJ, Wirth GA. Hemangiomas: An Overview. Clin Pediatr (Phila) 2007;46:206-21. [DOI: 10.1177/0009922806290455] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 6.2] [Reference Citation Analysis]
136 Holmes W, Mishra A, Gorst C, Liew S. Propranolol as first-line treatment for rapidly proliferating Infantile Haemangiomas. Journal of Plastic, Reconstructive & Aesthetic Surgery 2011;64:445-51. [DOI: 10.1016/j.bjps.2010.07.009] [Cited by in Crossref: 71] [Cited by in F6Publishing: 59] [Article Influence: 6.5] [Reference Citation Analysis]
137 Lang F, Press UP. [Infantile hemangioma of the eyelid]. Ophthalmologe 2017;114:1171-80. [PMID: 29147770 DOI: 10.1007/s00347-017-0604-x] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
138 Nguyen J, Fay A. Pharmacologic Therapy for Periocular Infantile Hemangiomas: A Review of the Literature. Seminars in Ophthalmology 2009;24:178-84. [DOI: 10.1080/08820530902805602] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
139 Soltani AM, Reinisch JF. Algorithmic approach to the management of hemangiomas. J Craniofac Surg 2011;22:585-8. [PMID: 21403532 DOI: 10.1097/SCS.0b013e31820873ac] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
140 Vasani RJ, Khanna D, Singal A. Cutaneous vascular lesions and their management in Indian setting: Cutaneous vascular lesions. Dermatol Ther 2012;25:358-75. [DOI: 10.1111/j.1529-8019.2012.01532.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
141 Fishman SJ, Fox VL. Visceral Vascular Anomalies. Gastrointestinal Endoscopy Clinics of North America 2001;11:813-34. [DOI: 10.1016/s1052-5157(18)30048-5] [Cited by in Crossref: 17] [Article Influence: 0.8] [Reference Citation Analysis]
142 Dotan M, Lorber A. Congestive heart failure with diffuse neonatal hemangiomatosis--case report and literature review. Acta Paediatr 2013;102:e232-8. [PMID: 23432737 DOI: 10.1111/apa.12184] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
143 Malik MA, Menon P, Rao KL, Samujh R. Effect of propranolol vs prednisolone vs propranolol with prednisolone in the management of infantile hemangioma: a randomized controlled study. J Pediatr Surg. 2013;48:2453-2459. [PMID: 24314186 DOI: 10.1016/j.jpedsurg.2013.08.020] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
144 Craiglow BG, Antaya RJ. Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches. Paediatr Drugs 2013;15:133-8. [PMID: 23456550 DOI: 10.1007/s40272-013-0008-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
145 Pandey A, Gangopadhyay AN, Gopal SC, Kumar V, Sharma SP, Gupta DK, Sinha CK. Twenty years' experience of steroids in infantile hemangioma—a developing country's perspective. Journal of Pediatric Surgery 2009;44:688-94. [DOI: 10.1016/j.jpedsurg.2008.10.038] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
146 Janmohamed SR, Madern GC, de Laat PC, Oranje AP. Educational paper: therapy of infantile haemangioma--history and current state (part II). Eur J Pediatr. 2015;174:259-266. [PMID: 25178895 DOI: 10.1007/s00431-014-2404-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
147 Hartzell LD, Buckmiller LM. Current Management of Infantile Hemangiomas and Their Common Associated Conditions. Otolaryngologic Clinics of North America 2012;45:545-56. [DOI: 10.1016/j.otc.2012.03.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
148 Greene AK. Management of hemangiomas and other vascular tumors. Clin Plast Surg 2011;38:45-63. [PMID: 21095471 DOI: 10.1016/j.cps.2010.08.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
149 Ritter MR, Dorrell MI, Edmonds J, Friedlander SF, Friedlander M. Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis. Proc Natl Acad Sci USA. 2002;99:7455-7460. [PMID: 12032304 DOI: 10.1073/pnas.102185799] [Cited by in Crossref: 120] [Cited by in F6Publishing: 115] [Article Influence: 6.0] [Reference Citation Analysis]
150 Ahronheim S. Combination therapy with epinephrine and dexamethasone for bronchiolitis. CJEM 2010;12:443-5. [DOI: 10.1017/s1481803500012604] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
151 Keller RG, Patel KG. Evidence-Based Medicine in the Treatment of Infantile Hemangiomas. Facial Plast Surg Clin North Am 2015;23:373-92. [PMID: 26208774 DOI: 10.1016/j.fsc.2015.04.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
152 Sainsbury DC, Kessell G, Fall AJ, Hampton FJ, Guhan A, Muir T. Intralesional bleomycin injection treatment for vascular birthmarks: a 5-year experience at a single United Kingdom unit. Plast Reconstr Surg. 2011;127:2031-2044. [PMID: 21532430 DOI: 10.1097/prs.0b013e31820e923c] [Cited by in Crossref: 55] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]